Abstract It recently has been hypothesized that increased plasma plasminogen activator inhibitor-1 (PAI-1) activity could be a possible link between insulin resistance and coronary heart disease. However, it is not known whether insulin sensitivity per se is a determinant of plasma PAI-1 activity or whether other intermediates could explain this association. We investigated the relationship between plasma PAI-1 activity and insulin sensitivity, obesity, distribution of body fat, blood pressure, plasma insulin concentration, and serum lipid levels in normoglycemic men (n=61) and women (n=77) 53 to 61 years old who participated in a previous population-based study. Insulin sensitivity was estimated by the minimal model from a frequently sampled intravenous glucose tolerance test. In univariate analyses, PAI-1 correlated positively with body mass index, waist-to-hip ratio (WHR), fasting and 2-hour insulin levels, and triglyceride level in both men and women. Furthermore, in women PAI-1 correlated inversely with highdensity lipoprotein (HDL) cholesterol level. There was an I mpairment of fibrinolysis has recently emerged as a risk factor for ischemic heart disease. Coronary artery thrombus formation plays a critical role in the pathogenesis of both unstable angina 1 and myocardial infarction (MI).
with untreated mild hypertension 15 - 17 have elevated PAI-1 levels. These factors also are features of the insulin resistance syndrome, 1819 and it has been hypothesized that an increased plasma PAI-1 level could be a possible link between insulin resistance and CHD. 20 PAI-1 level consistently has shown an inverse correlation with insulin sensitivity in univariate analyses 11121721 ; however, findings of the two studies 12 - 21 that reported results of multivariate analyses were contradictory. One study 21 stated that insulin sensitivity was the major determinant of PAI-1 antigen level; the other study 12 found that very-low-density lipoprotein (VLDL) triglyceride concentration, but not insulin sensitivity, was the principal correlate of plasma PAI-1 activity. In addition, previous studies have been limited to special subsets of the population, including obese subjects, 21 men, 12 - 17 or subjects selected according to the level of blood pressure (BP) 17 or the degree of obesity. 11 Only one study recruited subjects from a population survey, selecting them, however, by triglyceride concentration. 12 We investigated the relationship between plasma PAI-1 activity and insulin sensitivity estimated by the minimal model method, 22 obesity, BP, plasma insulin concentration, and serum lipid levels in normoglycemic middle-aged men and women who were participants of a previous population-based study. 23 We aimed particularly to examine whether insulin sensitivity is an independent determinant of PAI-1 activity and therefore a component of the insulin resistance syndrome or whether other intermediating factors could explain this association.
Methods

Subjects
The study subjects were a random sample of normoglycemic control subjects who had participated in a previous population-based study on atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in eastern and western Finland. 23 These subjects did not have impaired glucose tolerance or diabetes by World Health Organization criteria, 24 current treatment with oral corticosteroids, renal failure, or a serious illness within the previous month. The current age of the participants was 53 to 61 years and BMI was 20.2 to 36.9 kg/m 2 in men and 17.6 to 39.4 kg/m 2 in women.
25
Study Protocol
The study comprised two half-day visits to the metabolic ward of the Kuopio University Hospital (Kuopio, eastern Finland) or to the laboratory of the Rehabilitation Research Center of the Social Insurance Institution (Turku, western Finland). On day 1, an oral glucose tolerance test (75 g glucose) was performed between 7:30 and 9:30 AM after a 12-hour fast, and samples for blood glucose and plasma insulin were drawn during fasting and at 2 hours to exclude those with impaired glucose tolerance or diabetes. BMI was calculated as weight (kilograms) divided by height (meters) squared and was used as an index of overall adiposity. Waist-to-hip ratio (WHR) was measured as described previously. 25 BP was measured in the sitting position with a mercury sphygmomanometer after a 5-minute rest as described previously. 25 On day 2, 1 to 4 weeks after the oral glucose tolerance test, an insulin-modified frequently sampled intravenous glucose tolerance test (IVGTT) 26 -27 was performed as described previously 25 to evaluate insulin sensitivity. Glucose utilization was analyzed with the minimal model of glucose disappearance of Bergman and coworkers. 22 Between 7 and 9 AM after a 12-hour fast, blood for measurements of lipids, lipoproteins, PAI-1, and fibrinogen was drawn, and the IVGTT was started.
Informed consent was obtained from all participants after the purpose and potential risks of the study were explained to them. The protocol was approved by the Ethics Committee of the University of Kuopio.
Laboratory Methods
Blood glucose, plasma insulin, serum lipids, and lipoproteins were assayed as described previously. 25 ' 2831 Venous blood samples for determination of plasma PAI-1 and fibrinogen were drawn between 7 and 9 AM after a 12-hour overnight fast into chilled trisodium citrate tubes and immediately cooled on ice. The collected blood was centrifuged within 30 minutes at 3800g for 20 minutes at 4°C to obtain platelet-free plasma, frozen quickly in aliquots, and stored at -70°C. Plasma samples were assayed for PAI-1 activity with a commercial two-stage indirect enzymatic assay (Spectrolyse, Biopool AB) as described by Eriksson et al. 32 The intra-assay coefficient of variation of the method was 6.5% in our studies. Fibrinogen was determined according to Gauss. 33 The intra-assay coefficient of variation for the fibrinogen method was less than 5%.
Statistical Methods
Data analyses were performed with the SPSS/PC+ statistical software. 34 The results for continuous variables are given as mean±SEM. Student's two-tailed t test for independent samples was used in assessment of the significance of difference between group means. Pearson product-moment correlation, partial correlation adjusted for sex, and multivariate stepwise linear regression analyses were used to investigate the association between PAI-1 and other variables. Interaction between 20 . Correlations between PAI-1 activity and fibrinogen concentration and insulin sensitivity were similar in eastern and western Finland, so the population samples were pooled. To improve skewness and kurtosis of the distributions, PAI-1 activity, triglyceride, and insulin values were logarithmically transformed for statistical analyses and then back-transformed to their natural units for presentation in the tables. Distributions of all other variables were normal.
Results
Characteristics of the study population are given in Table 1 . There were no differences in fasting and 2-hour plasma glucose levels or in fasting plasma insulin levels between men and women, but women had higher 2-hour plasma insulin levels than men. However, insulin sensitivity was higher in women than in men (men: range, 0.35 to 10.20x 10"
; women: range, 0.64 to ' 1 4 ll.OxlO" 4 min mL" 1 ; median, 3.53xl0" min" 1 • /j,U"' • mL" 1 ). There was no sex difference in PAI-1 level (men: range, 0 to 36.6 U/mL; median, 7.5 U/mL; women: 0 to 65.5 U/mL; median, 6.8 U/mL), but men had higher plasma fibrinogen levels than women. Table 2 Insulin sensitivity correlated significantly inversely with BMI, WHR, fasting and 2-hour insulin levels, triglyceride level, and PAI-1 activity in both men and women (Table 2 ). There was a significant positive correlation between insulin sensitivity and HDL cholesterol level in both sexes. In men, the strongest correlates of insulin sensitivity were fasting (/•= -.65, /*<.001) and 2-hour (r=-.68, / > <.001) insulin levels. In women, fasting (r= -.53) and 2-hour (r= -.61) insulin levels and WHR (r= -.56) were most strongly (Z'<.001) related to insulin sensitivity.
Fibrinogen concentration did not correlate with PAI-1 activity or with insulin sensitivity, and therefore fibrinogen was not included in the further analyses.
To investigate which variables may explain the association between insulin sensitivity and PAI-1 activity, bivariate linear regression analyses were performed (Table 3) . Independent variables in these analyses were insulin sensitivity and each of the variables showing significant correlation with PAI-1 activity in univariate analyses. In men, BMI (model 1) and triglyceride level (model 3) accounted significantly for the relation between insulin sensitivity and PAI-1 activity. Adjustment for triglyceride level abolished the association between insulin sensitivity and PAI-1 activity. In contrast, WHR and HDL cholesterol level were not significantly associated with PAI-1 activity independent of insulin sensitivity in men. In women, BMI (model 1), WHR (model 2), and HDL cholesterol level (model 4) partly explained the association between insulin sensitivity and PAI-1 activity, but the association between insulin sensitivity and PAI-1 lost its statistical significance only after the adjustment for WHR. However, triglyceride level was not significantly related to PAI-1 activity independent of insulin sensitivity in women.
To further investigate the association between insulin sensitivity and PAI-1 activity, multivariate stepwise linear regression analyses were performed (Table 4) . Independent variables in these analyses were insulin sensitivity and the variables that were significantly related to PAI-1 activity in bivariate analyses, ie, BMI and triglyceride level in men and BMI, WHR, and HDL cholesterol level in women. In men insulin sensitivity failed to show any significant association with PAI-1. In contrast, triglyceride level and BMI were independently associated with PAI-1 activity. Triglyceride level explained 23% of the variation of PAI-1 activity in men, and the overall R 2 for the model was 30%. Also, in women insulin sensitivity was not independently associated with PAI-1. In women, WHR and HDL cholesterol level were independently related to PAI-1, and together they explained 32% of the variation in PAI-1 activity.
Multivariate stepwise linear regression analyses also were performed after pooling the data for men and women (Table 4) . Two different models were applied; model 1 included insulin sensitivity, sex, BMI, WHR, and triglyceride level as independent variables; in model 2, triglyceride level was replaced by HDL cholesterol level. In model 1, BMI and triglyceride level were independently associated with plasma PAI-1, and together they explained 22% of the variation in PAI-1 activity. However, insulin sensitivity did not enter into this model. When HDL cholesterol level was included in Line plots show linear correlation of plasminogen activator inhibitor-1 (PAI-1) activity with waist-to-hip ratio (A), 2-hour insulin (B), trigtyceride (C), and insulin sensitivity (D) in men (upper panels) and women (lower panels). Note that PAI-1, 2-hour insulin, and triglyceride values are logarithmically transformed. Corresponding correlation coefficients are shown in Table 2 . the model instead of triglyceride level, BMI and insulin sensitivity were independently associated with PAI-1, explaining 22% of the variation in PAI-1 activity.
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Multivariate linear regression analyses also were done using 2-hour insulin level instead of insulin sensitivity as an independent variable (Table 5) . Also in this analysis, in men triglyceride level and BMI were independently associated with PAI-1 activity. In women, independent determinants of PAI-1 activity were WHR and 2-hour insulin level, which explained 33% of the variation in PAI-1 activity. When data for men and women were pooled in the analysis, BMI, 2-hour insulin level, and WHR (model 1) or BMI, 2-hour insulin level, and HDL cholesterol level (model 2) were independently associated with PAI-1 activity.
Results from the univariate correlation and bivariate regression analyses done separately for men and women suggested that determinants for PAI-1 activity may be different in men and women. Therefore, we examined whether sex and the major correlates with PAI-1 activity had an interaction in multivariate regression analyses on PAI-1 activity. No significant (P>.20) interactions between BMI, WHR, triglyceride level, HDL cholesterol level, fasting insulin level, or insulin sensitivity and sex were found. However, 2-hour insulin level and sex showed a statistically significant (P=.O28) positive inter- .047
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PAI-1 indicates plasminogen activator inhibitor-1; HDL, high-density lipoprotein. /3 denotes the standardized regression coefficient. Both independent variables were entered into the model at the same time.
action, implying that the association of 2-hour insulin level on PAI-1 activity was stronger in women than men.
Discussion
Results of this population-based study suggest that adiposity and serum triglyceride and HDL cholesterol concentrations explain the association between insulin sensitivity and plasma PAI-1 activity in normoglycemic subjects. Our study is the first to demonstrate that the major correlates of plasma PAI-1 activity are different in men and women. Most previous studies were conducted with only men 1217 or women, 11 and only one study included both men and women but pooled the data. 21 Our study confirmed previous findings that obesity 9 -12 and central body fat distribution 1012 are linked closely to high PAI-1 levels. In addition to obesity, high triglyceride concentration in men and high 2-hour plasma insulin concentration in women were statistically independently related to plasma PAI-1 activity in our study population as in previous reports. 4 -911121517 Interventional studies 3537 suggest that the association between obesity and high PAI-1 level is mediated partly by high plasma insulin and triglyceride levels related to obesity. Administration of metformin 35 simultaneously decreased plasma insulin, triglyceride, and PAI-1 levels in obese subjects. Furthermore, weight loss leads to a decrease in plasma insulin, triglyceride, and PAI-1 levels. 3 " 7 In the present study as well as in several previous studies, 111217 -21 plasma PAI-1 activity correlated inversely with insulin sensitivity in univariate analyses in both men 12 -17 and women. 11 However, after we accounted for the effect of obesity, body fat distribution, and triglyceride or HDL cholesterol concentrations, insulin sensitivity was no longer statistically significantly associated with plasma PAI-1 activity. In multivariate analysis, serum triglyceride level and BMI were independently related to plasma PAI-1 activity in men, which is in accordance with a recent population-based study. 12 In women, WHR and HDL cholesterol level were independently associated with plasma PAI-1 activity. No previous study has reported results on independent correlates of plasma PAI-1 activity in women. Our results seem to contrast with results of a recent study, 21 which found that peripheral insulin resistance per se was most strongly associated with plasma PAI-1 antigen level in men and women. One possible explanation for this controversy is that our study was a population-based study in normoglycemic subjects, whereas subjects in the previous study were obese nondiabetic and obese type II diabetic men and women. It may be that in obese subjects determinants of plasma PAI-1 level are somewhat different compared with a population-based sample in which there is a broader range of body weight. Furthermore, factors associated with high PAI-1 level may vary between normoglycemic and diabetic subjects. Finally, differences in techniques could explain some of the discrepancies between these two studies: the previous study used sequential hyperinsulinemic euglycemic clamps to measure the degree of insulin resistance, whereas we used frequently sampled IVGTT and the minimal model.
Findings of the present study suggest that the major correlates of plasma PAI-1 activity may be different in p denotes the standardized regression coefficient. All regression models included insulin sensitivity (S,) as an independent variable. In addition, in men potential independent variables included body mass index and triglyceride level and in women, body mass index, waist-to-hip ratio, and HDL cholesterol level. Analyses that pooled men and women included the following variables as potential independent variables: insulin sensitivity, sex, body mass index, waist-to-hip ratio, and triglyceride level (model 1) or HDL cholesterol level (model 2). Probability value for variable entry into the regression models was <. 10. men and women. Serum triglyceride level and BMI were independently associated with plasma PAI-1 activity in all analyses in men. In women, WHR and HDL cholesterol level (analysis including insulin sensitivity as an independent variable) or WHR and 2-hour insulin level (analysis including 2-hour insulin as an independent variable) were independently associated with plasma PAI-1 activity. Furthermore, the 2-hour insulin level had an interaction with sex on PAI-1 activity, implying that this association was stronger in women than men. Associations between sex hormones and plasma PAI-1 activity could partly explain these findings. In men, serum testosterone level 38 -39 is inversely and the serum estradiol-to-testosterone ratio 38 is positively correlated with plasma PAI-1 activity. Furthermore, in men the association between serum testosterone and serum estradiol-to-testosterone ratio and plasma PAI-1 activity was markedly stronger than the relationship between plasma insulin and PAI-1 activity in one study. 38 Nevertheless, in normoglycemic men low testosterone level is related to high insulin 40 and in diabetic men to high triglyceride 41 concentrations, which could be mediators between testosterone level and PAI-1 activity. It is not known how sex hormones are related to plasma PAI-1 activity in women. .297
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PAI-1 indicates plasminogen activator inhibitor-1; HDL, highdensity lipoprotein.
f} denotes the standardized regression coefficient. All regression models included 2-hour insulin concentration as an independent variable. In addition, in men potential independent variables included body mass index and triglyceride level and in women, body mass index, waist-to-hip ratio, and HDL cholesterol level. Analyses that pooled men and women included the following variables as potential independent variables: 2-hour insulin concentration, sex, body mass index, waist-to-hip ratio, and triglyceride level (model 1) or HDL cholesterol level (model 2). Probability value for variable entry into the regression models was <.10.
The relation between WHR and plasma PAI-1 activity was more marked in women than men. One possible explanation for this is the sex difference in body fat distribution; abdominal fat distribution is typical for men and gluteal fat distribution is typical for women. 42 Thus, in women an increase in WHR means a redistribution of fat from the gluteal to the abdominal region, ie, to a metabolically active compartment, whereas in men it only strengthens the already existing adverse fat distribution. There is likely to be a plateau effect on the association between central obesity and PAI-1 activity in men in whom WHR is high.
In vitro studies have elucidated the mechanisms by which insulin sensitivity could regulate plasma PAI-1 activity. In vitro, PAI-1 is synthesized by endothelial cells 43 and hepatocytes. 44 Insulin stimulates PAI-1 production by the hepatoma cell line Hep G2 45 and in cultures of human hepatocytes 46 but not in endothelial cell cultures. 45 In vivo findings on the effects of insulin on PAI-1 synthesis are, however, contradictory. In clamp studies, acute administration of exogenous insu-lin did not change plasma PAI-1 activity, 4748 whereas an acute rise in endogenous insulin following an oral glucose load induced an increase in plasma PAI-1 activity. 49 It is possible that the portal vein insulin concentration is important in regulating PAI-1 synthesis in hepatocytes. Plasma insulin levels achieved in the clamp studies 47 ' 48 were markedly lower than insulin concentrations in the previous in vitro studies 45 - 46 and in the rat portal vein after a meal. 50 Furthermore, patients with insulin-dependent diabetes have low portal insulin levels and normal to low plasma PAI-1 activity, 51 whereas patients with non-insulin-dependent diabetes have portal and systemic hyperinsulinemia and elevated plasma PAI-1 activity. 16 In addition to a direct effect of PAI-1 synthesis by hepatocytes, insulin may influence plasma PAI-1 activity indirectly through its effect on plasma triglyceride level. Recently it was shown that purified VLDL stimulates PAI-1 secretion by endothelial cells. 52 Moreover, VLDL from hypertriglyceridemic subjects was more effective in increasing PAI-1 production than was VLDL from normotriglyceridemic subjects.
In conclusion, low insulin sensitivity was associated with high plasma PAI-1 activity. Insulin sensitivity was, however, not an independent determinant of PAI-1 activity, but obesity, central body fat distribution, and serum triglyceride and HDL cholesterol concentrations were intermediates in the association between insulin sensitivity and plasma PAI-1 activity. Therefore, the evidence from the present study does not support the notion that PAI-1 should be considered as a component of the insulin resistance syndrome.
